Article Publish Status: FREE
Abstract Title:

Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials.

Abstract Source:

Ann Oncol. 2019 May ;30(5):733-743. Epub 2019 Dec 4. PMID: 31987340

Abstract Author(s):

N Keum, D H Lee, D C Greenwood, J E Manson, E Giovannucci

Article Affiliation:

N Keum


BACKGROUND: Previous meta-analyses of randomized controlled trials (RCTs) of vitamin D supplementation and total cancer incidence and mortality found inconsistent results, and most included trials administered generally low doses of vitamin D (≤1100IU/day). We updated the meta-analysis by incorporating recent RCTs that have tested higher doses of vitamin D supplements.

MATERIALS AND METHODS: PubMed and Embase were searched from the inception to November 2018. Summary relative risks (RRs) and 95% confidence intervals (CIs) were estimated using a random-effects model.

RESULTS: For total cancer incidence, 10 trials were included [6537 cases; 3-10years of follow-up; 54-135nmol/l of attained levels of circulating 25(OH) vitamin D [25(OH)D] in the intervention group]. The summary RR was 0.98 (95% CI, 0.93-1.03; P = 0.42; I= 0%). The results remained null across subgroups tested, including even when attained 25(OH)D levels exceeded 100nmol/l (RR, 0.95; 95% CI, 0.83-1.09; P = 0.48; I= 26%). For total cancer mortality, five trials were included [1591 deaths; 3-10years of follow-up; 54-135nmol/l of attained levels of circulating 25(OH)D in the intervention group]. The summary RR was 0.87 (95% CI, 0.79-0.96; P = 0.005; I= 0%), which was largely attributable to interventions with daily dosing (as opposed to infrequent bolus dosing). No statistically significant heterogeneity was observed by attained levels of circulating 25(OH)D (P= 0.83), with RR being 0.88 (95% CI, 0.78-0.98; P = 0.02; I= 0%) for≤100nmol/l and 0.85 (95% CI, 0.70-1.03; P = 0.11; I= 0%) for>100nmol/l.

CONCLUSIONS: In an updated meta-analysis of RCTs, vitamin D supplementation significantly reduced total cancer mortality but did not reduce total cancer incidence.

Study Type : Meta Analysis

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.